Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
17.60
+0.58 (3.41%)
Jun 6, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Dermatologic
257.00M
Log In
Log In
Log In
Log In
Upgrade
Dermatologic Growth
40.15%
Log In
Log In
Log In
Log In
Upgrade
Non-Dermatologic
75.07M
Log In
Log In
Log In
Log In
Upgrade
Non-Dermatologic Growth
106.17%
Log In
Log In
Log In
Log In
Upgrade
Diagnostic and Prognostic Cancer Test
-
Log In
Log In
Log In
Log In
Upgrade
Diagnostic and Prognostic Cancer Test Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
332.07M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
51.09%
Log In
Log In
Log In
Log In
Upgrade